William Blair Weighs in on Astrana Health Q2 Earnings

Astrana Health, Inc. (NASDAQ:ASTH - Free Report) - Equities researchers at William Blair issued their Q2 2026 earnings per share (EPS) estimates for shares of Astrana Health in a research note issued to investors on Wednesday, July 2nd. William Blair analyst R. Daniels anticipates that the company will earn $0.45 per share for the quarter. The consensus estimate for Astrana Health's current full-year earnings is $1.15 per share. William Blair also issued estimates for Astrana Health's Q3 2026 earnings at $0.46 EPS.

Several other equities research analysts also recently commented on ASTH. Barclays began coverage on shares of Astrana Health in a research note on Tuesday, April 1st. They issued an "equal weight" rating and a $36.00 target price for the company. Truist Financial lowered their price objective on shares of Astrana Health from $50.00 to $46.00 and set a "buy" rating for the company in a research report on Tuesday, March 18th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, Astrana Health has an average rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Stock Performance

Shares of NASDAQ:ASTH opened at $25.28 on Friday. The firm's 50 day simple moving average is $26.76 and its 200 day simple moving average is $30.83. Astrana Health has a fifty-two week low of $23.12 and a fifty-two week high of $63.20. The company has a market capitalization of $1.42 billion, a price-to-earnings ratio of 35.10, a P/E/G ratio of 1.33 and a beta of 0.84. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). Astrana Health had a net margin of 1.56% and a return on equity of 4.90%. The company had revenue of $620.39 million during the quarter, compared to the consensus estimate of $628.11 million. During the same quarter in the prior year, the company posted $0.31 EPS. The company's revenue for the quarter was up 53.4% compared to the same quarter last year.

Hedge Funds Weigh In On Astrana Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Astrana Health in the 4th quarter valued at about $40,000. Quarry LP raised its position in Astrana Health by 35.5% in the 4th quarter. Quarry LP now owns 1,799 shares of the company's stock valued at $57,000 after buying an additional 471 shares during the last quarter. Covestor Ltd raised its position in Astrana Health by 777.6% in the 1st quarter. Covestor Ltd now owns 2,001 shares of the company's stock valued at $62,000 after buying an additional 1,773 shares during the last quarter. US Bancorp DE lifted its stake in Astrana Health by 3,880.0% in the 4th quarter. US Bancorp DE now owns 4,776 shares of the company's stock valued at $151,000 after acquiring an additional 4,656 shares in the last quarter. Finally, AlphaQuest LLC boosted its position in Astrana Health by 144.2% during the 1st quarter. AlphaQuest LLC now owns 4,883 shares of the company's stock worth $151,000 after acquiring an additional 2,883 shares during the last quarter. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.